165
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Features and Predictive Nomogram of Acute Kidney Injury in Aging Population Infected with SARS-CoV-2 Omicron Variant

, , , , , , , , , , , , , & show all
Pages 2967-2978 | Received 18 Apr 2023, Accepted 11 Jul 2023, Published online: 18 Jul 2023

References

  • Cai J, Deng X, Yang J, et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med. 2022;28(7):1468–1475.
  • WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/. Accessed July 12, 2023.
  • Cui Z, Liu P, Wang N, et al. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell. 2022;185(5):860–871 e13.
  • Iketani S, Liu L, Guo Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022;604(7906):553–556.
  • Jingwen A, Wang X, Xinyi H, et al. Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages. Cell Host Microbe. 2022;30(8):1077–1083 e4.
  • Information Office of Shanghai Municipality. Shanghai reports on the prevention and control of COVID-19; 2022. Available from: https://www.shio.gov.cn/TrueCMS/shxwbgs/2022n_6y/2022n_6y.html. Accessed July 12, 2023.
  • Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437–446.
  • Karunanithi S. Omicron and the NHS: we need to look beyond hospital care to solve the pressures. BMJ. 2022;376:o185.
  • Chan L, Chaudhary K, Saha A, et al. AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151–160.
  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838.
  • Ng JH, Hirsch JS, Hazzan A, et al. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis. 2021;77(2):204–215 e1.
  • Kellum JA, Norbert Lameire PA, Barsoum RS, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):138.
  • Mehta RL, Burdmann EA, Cerdá J, et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet. 2016;387(10032):2017–2025.
  • Eckardt K-U, Kasiske BL. Kidney disease: improving global outcomes. Nat Rev Nephrol. 2009;5(11):650–657.
  • Macedo E, Hemmila U, Kumar Sharma S, et al. Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: a multi-country feasibility study. PLoS Med. 2021;18(1):e1003408.
  • Ostermann M, Bellomo R, Burdmann EA, et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Conference. Kidney Int. 2020;98(2):294–309.
  • NHCotPsRo C. Notice on printing and distributing the COVID-19 pneumonia diagnosis and treatment plan (ninth trial version) 2022; 2022. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml. Accessed July 12, 2023.
  • D’ascanio M, Innammorato M, Pasquariello L, et al. Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes. BMC Geriatr. 2021;21(1):63.
  • Hong X, Garcia-Ptacek S, Annetorp M, et al. Acute kidney injury and mortality risk in older adults with COVID-19. J Nephrol. 2021;34(2):295–304.
  • Scarpioni R, Valsania T, Albertazzi V, et al. Acute kidney injury, a common and severe complication in hospitalized patients during the COVID-19 pandemic. J Nephrol. 2021;34(4):1019–1024.
  • Lee JR, Silberzweig J, Akchurin O, et al. Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center. Clin J Am Soc Nephrol. 2021;16(2):284–286.
  • Fisher M, Neugarten J, Bellin E, et al. AKI in Hospitalized Patients with and without COVID-19: a Comparison Study. J Am Soc Nephrol. 2020;31(9):2145–2157.
  • Xia P, Wen Y, Duan Y, et al. Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: a Retrospective Cohort. J Am Soc Nephrol. 2020;31(9):2205–2221.
  • Lin L, Wang X, Ren J, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 2020;10(11):e042573.
  • Bell JS, James BD, Al-Chalabi S, et al. Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients. BMC Nephrol. 2021;22(1):269.
  • Pan Y, Wang W, Jinwei W, et al. Incidence and Risk Factors of in-hospital mortality from AKI after non-cardiovascular operation: a nationwide Survey in China. Sci Rep. 2017;7(1):13953.
  • Wainstein M, MacDonald S, Fryer D, et al. Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: a multinational study using the ISARIC-WHO clinical characterisation protocol. PLoS Med. 2022;19(4):e1003969.
  • Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-World Evidence - What Is It and What Can It Tell Us? N Engl J Med. 2016;375(23):2293–2297.
  • Zhang N-H, Cheng Y-C, Luo R, et al. Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital. BMC Infect Dis. 2021;21(1):397.
  • Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232.
  • Hua S, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–227.
  • Shabnam Salimi M, John M, Hamlyn P. COVID-19 and Crosstalk With the Hallmarks of Aging. J Gerontol a Biol Sci Med Sci. 2020;75(9):e34–e41.
  • Wang W, Chen J, Xueqing Y, et al. Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation. Int J Biol Sci. 2022;18(12):4704–4713.
  • Coutard B, Valle C, de Lamballerie X, et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742.
  • van de Sandt CE, Bárcena M, Koster AJ, et al. Human CD8+ T Cells Damage Noninfected Epithelial Cells during Influenza Virus Infection In Vitro. Am J Respir Cell Mol Biol. 2017;57(5):536–546.
  • Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615.
  • Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun. 2021;12(1):2506.
  • Vabret N, Britton GJ, Gruber C, et al. Immunology of COVID-19: current State of the Science [review]. Immunity. 2020;52(6):910–941.
  • Yijia L, Schneider AM, Mehta A, et al. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J Clin Invest. 2021;131(13):e148635.